Showcasing the most successful biopharmaceutical companies in France.

BioFrance is a growing and successful biotech community. France has established itself as a contender among Europe’s leading biopharmaceutical hotbeds, ranking fifth in Phase III public company pipelines in Europe, according to Ernst & Young. With a rise in venture capital, BioFrance shows promise of continuing expansion and development of products and research.

Join the World Discussion Forum

Hotbed News
ERYtech Pharma Announces Enrollment Of First Patient In Phase II Study Of ERY-ASP In Pancreatic Cancer Monday, July 28, 2014
Corporate Governance Developments At BIOASTER, Institute For Technology Research In Health Monday, July 28, 2014
Theraclion Receives €900 Thousand From Bpifrance's "Industrial Strategic Innovation" Program To Fund Development Of A New Treatment System In Collaboration With Supersonic Imagine Friday, July 25, 2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial Friday, July 25, 2014
QIAGEN N.V. (QGEN) Adds Promising Genomic Biomarkers For Assessing Prognosis In Treatment Of Blood Cancers To Personalized Healthcare Pipeline Friday, July 25, 2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 Friday, July 25, 2014
THERAVECTYS Files Suit In The U.S. Against Immune Design Corporation (IMDZ) Friday, July 25, 2014
Adocia Reports Operational And Financial Results For The First Half Of 2014 Thursday, July 24, 2014
Stentys First Half 2014 Revenues Rise 18% Thursday, July 24, 2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen Thursday, July 24, 2014